Compounds > n,n-dimethyl-3,3-diphenyl-1-methylallylamine
Page last updated: 2024-09-03

n,n-dimethyl-3,3-diphenyl-1-methylallylamine and Neoplasms

n,n-dimethyl-3,3-diphenyl-1-methylallylamine has been researched along with Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kjaer, M; Nielsen, H1

Other Studies

1 other study(ies) available for n,n-dimethyl-3,3-diphenyl-1-methylallylamine and Neoplasms

ArticleYear
Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin.
    Acta oncologica (Stockholm, Sweden), 1988, Volume: 27, Issue:5

    Topics: Administration, Oral; Adult; Aged; Allylamine; Amines; Drug Combinations; Female; Half-Life; Humans; Male; Meperidine; Middle Aged; Neoplasms; Pain, Intractable; Tablets

1988